Synergistic effects of verapamil and anti-mdr1 ribozyme on reversion of multidrug resistance in the P-glycoprotein-positive K562 cell line

Leukemia. 2001 Apr;15(4):696-7. doi: 10.1038/sj.leu.2402072.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
  • Drug Resistance, Multiple*
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Humans
  • K562 Cells
  • RNA, Catalytic / pharmacology*
  • Verapamil / pharmacology*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • RNA, Catalytic
  • Verapamil